Astrocytoma
Showing NaN - NaN of 5
Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard
Completed
- Glioblastoma
- +4 more
- Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
- Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 18, 2021
Glioblastoma Multiforme, Astrocytoma, Gliomas, Malignant Trial in United States (Toca 511 vector, Toca FC • Flucytosine • 5-FC •
Terminated
- Glioblastoma Multiforme
- +2 more
- Toca 511 vector
- Toca FC • Flucytosine • 5-FC • 5-Fluorocytosine
-
Los Angeles, California
- +10 more
Mar 26, 2020
Oligodendroglioma, Astrocytoma, Malignant Glioma Trial in United States (PF-06840003)
Terminated
- Oligodendroglioma
- +2 more
-
Los Angeles, California
- +13 more
Jan 13, 2020
Glioma, Astrocytoma, Oligodendroglioma Trial in United States (Temozolomide and O6-Benzylguanine)
Terminated
- Glioma
- +3 more
- Temozolomide and O6-Benzylguanine
-
Los Angeles, California
- +11 more
Feb 7, 2012
